GEO Investing

We believe that REPRO MED SYS INC (OOTC:REPR) can more than double from its recent trading price, but there are risks. The Company has been under a cloud since the FDA issued a warning letter concerning the company’s Freedom 60 Syringe […]

We have been highlighting the continuous open market purchases of Repro-Med Systems (OOTC:REPR) shares by Joseph Manko of Horton Capital Management the last several months.  The last filing was on February 17,2016 which disclosed a purchase of 21,900 shares bringing Horton […]

GeoInvesting has been covering Repro-Med Systems (OOTC:REPR) for several years and in mid 2014, we explained that the company’s history of growing revenues would eventually garner investor attention. Yesterday, the stock’s price matched its 52-week high, which also happens to be the […]

The GeoTeam has been monitoring developments that might impact REPRO MED SYS INC (OOTC:REPR) and its flagship product, the FREEDOM60 pump (mechanical infusion pump system) and related needle sets used to deliver medication to primary immune deficiency patients. We noted that […]